Research any topic before you write.
Find related topics. | Discover entities. | See connections. | Build a topical map.
Etanercept, sold under the brand name Enbrel among others, is a biologic medical product that is used to treat autoimmune diseases by interfering with tumor necrosis factor (TNF), a soluble inflammatory cytokine, by acting as a TNF inhibitor. It has US Food and Drug Administration (FDA) approval to treat rheumatoid arthritis, juvenile idiopathic…
History, Community, Culture & Applications
Explore the main themes, entities and connections around Etanercept. Start with the topic map, then use the sections below for research and deeper semantic analysis.
Start with a few of the strongest sections from the source topic. These are research directions, not a list of keywords you must use.
High-confidence facts extracted from structured source data. Use them as anchors for further research.
Browse the full topic structure. Each item opens a new analysis centered on that subject.
Deeper signals for content research, entity SEO and topical coverage. The plain-language headings explain what each technical view is useful for.
See the strongest relationship patterns around the current topic before diving into the raw triples.
Use these terms to understand the vocabulary surrounding the topic, not as a checklist for keyword stuffing.
tnf us protein use receptor dna diseases igg1 approved response fusion fc medical european union soluble treat autoimmune immune first
| Subject | Predicate | Object | Confidence | Src |
|---|---|---|---|---|
| Etanercept | AHFS/Drugs.com | Monograph | 1.00 | infobox |
| Etanercept | ATC code | L04AB01 (WHO) | 1.00 | infobox |
| Etanercept | Bioavailability | 58–76% (SC) | 1.00 | infobox |
| Etanercept | Biosimilars | etanercept-szzs, etanercept-ykro, Benepali, Brenzys, Erelzi, Etacept, Etera, Eticovo, Fubelv, Lifmior, Nepexto, Rymti | 1.00 | infobox |
| Etanercept | CAS Number | 185243-69-0 | 1.00 | infobox |
| Etanercept | ChEMBL | ChEMBL1201572 | 1.00 | infobox |
| Etanercept | ChemSpider | None | 1.00 | infobox |
| Etanercept | CompTox Dashboard (EPA) | DTXSID8040850 | 1.00 | infobox |
| Etanercept | DrugBank | DB00005 | 1.00 | infobox |
| Etanercept | ECHA InfoCard | 100.224.383 | 1.00 | infobox |
| Etanercept | Elimination half-life | 70–132 hours | 1.00 | infobox |
| Etanercept | Formula | C2224H3475N621O698S36 | 1.00 | infobox |
| Etanercept | KEGG | D00742 | 1.00 | infobox |
| Etanercept | Legal status | AU: S4 (Prescription only) | 1.00 | infobox |
| Etanercept | Legal status | CA: ℞-only / Schedule D | 1.00 | infobox |
| Etanercept | Legal status | UK: POM (Prescription only) | 1.00 | infobox |
| Etanercept | Legal status | US: ℞-only | 1.00 | infobox |
| Etanercept | Legal status | EU: Rx-only | 1.00 | infobox |
| Etanercept | License data | US DailyMed: Etanercept | 1.00 | infobox |
| Etanercept | MedlinePlus | a602013 | 1.00 | infobox |
| Etanercept | Molar mass | 51235.07 g·mol−1 | 1.00 | infobox |
| Etanercept | Pregnancy category | AU: D | 1.00 | infobox |
| Etanercept | PubChem SID | 7847807 | 1.00 | infobox |
| Etanercept | Routes of administration | Subcutaneous | 1.00 | infobox |
| Etanercept | Trade names | Enbrel | 1.00 | infobox |
| Etanercept | UNII | OP401G7OJC | 1.00 | infobox |
| Etanercept | is a | fusion protein produced by recombinant DNA | 0.90 | text |
| Etanercept | is a | therapeutic alternative on the World Health Organization's List of Essential Medicines | 0.90 | text |
| Etanercept | is a | complex molecule containing 6 N-glycans | 0.90 | text |
These clusters group vocabulary that occurs around closely connected concepts in the source material.
Bridges can reveal useful research angles that are easy to miss in a flat list of related terms.